Gå till Team

Geoff Nash

Director

Geoff is a director at Oaklins Cavendish, one of Oaklins’ member firms in the UK, and heads its ECM activities. He has over 20 years’ corporate finance experience in growth companies, having advised on all aspects of IPO, M&A and secondary funding. Geoff has advised clients across a range of sectors, with a particular focus on life sciences. His clients include Avacta plc, Synairgen plc, Bioventix plc and Tristel plc.

Prior to joining the team, Geoff qualified with KPMG and previously worked in private equity. He also spent seven years at Evolution Securities (formerly Beeson Gregory and now part of Investec).

 Geoff Nash
Plats
London, Storbritannien

Email
g.nash@cavendish.oaklins.com

Arbetstelefon
+44 20 7220 0563

Hälsovård

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Lär dig mer
Konsument- & detaljhandel

Revolution Bars Group plc has completed a fundraising

Lär dig mer
Industriella maskiner och komponenter

Sondrel secures a major investment

Lär dig mer